Pregnancy News and Research

Latest Pregnancy News and Research

Antidepressants during first trimester linked to increased risk of autism

Prenatal exposure to selective serotonin reuptake inhibitors, especially during the first trimester, is associated with a modest increase the risk of developing an autism spectrum disorder, according to a report published Online First in the Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jul 2011

Autism Speaks announces significant findings from largest study of twins with ASD

Autism Speaks, the world's largest autism science and advocacy organization, joined in announcing significant findings from the largest known study of twins with autism spectrum disorder.

5 Jul 2011

Anti-depressants during early pregnancy linked to increased risk of autism

Exposure to selective serotonin reuptake inhibitors anti-depressants in early pregnancy may modestly increase risk of autism spectrum disorders, according to a Kaiser Permanente study published online in the current issue of Archives of General Psychiatry.

5 Jul 2011

Shared environment influences susceptibility to autism more than previously thought

The largest and most rigorous twin study of its kind to date has found that shared environment influences susceptibility to autism more than previously thought.

5 Jul 2011

Hope for fertility spreads through postcards

The campaign sends a multiplied message of hope for fertility in form of postcards with stories, including the key message on prevention and treatment. Thousands of postcards with moving stories are expected to cross Europe until October 2011.

4 Jul 2011

Research addresses chromosomal imbalance in embryos

Joint research between the University of Kent's Professor Darren Griffin, London Bridge Fertility Centre and BlueGnome Ltd has addressed chromosomal imbalance in embryos, a condition that is currently the major cause of pregnancy loss in IVF.

4 Jul 2011

Study shows effect of maternal height on multiple implantation

The researchers say that this is the first time the effect of maternal height on multiple implantation has been shown.

4 Jul 2011

Women can have successful pregnancy after recurrent miscarriage

In a subset of the ALIFE study, which investigated the effect of aspirin alone or combined with low-molecular-weight heparin, compared to placebo, on the live birth rate in women with unexplained RM, the researchers looked at the length of time between the moment of randomisation to the moment of the first day of last menstruation before the subsequent pregnancy.

4 Jul 2011

Primiparity, maternal smoking and BMI linked to risk of pre-term birth

In Sweden almost 40 000 children have now been born after IVF, around 3 500 each year, and IVF children constitute 3% of all newborns. "This represents a large number of children and any adverse outcomes related to IVF are therefore a major public health issue," said Dr. Antonina Sazonova, from Sahlgrenska University Hospital, Gothenburg, Sweden, who carried out the research with colleagues from the hospital and from Lund University.

4 Jul 2011

New model may help reduce multiple pregnancies in women

Dr Jan Holte told the annual meeting of the European Society for Human Reproduction and Embryology, that if this model were to be applied in all fertility clinics, it had the potential to reduce the twin rates to the level of just under two percent seen in the normal population. Already, another four clinics have started to use the model.

4 Jul 2011

New insight into oocyte chromosome abnormalities

Ovarian stimulation undertaken by women of advanced maternal age receiving fertility treatment may be disrupting the normal pattern of meiosis - a critical process of chromosome duplication followed by two specialised cell divisions in the production of oocytes and sperm - and leading to abnormalities of chromosome copy numbers that result in IVF failure, pregnancy loss or, more rarely, the birth of affected children with conditions such as Down's syndrome, which is caused by the inheritance of three copies of chromosome 21.

4 Jul 2011

Judge halts enforcement of S.D. abortion law; hearing on Kansas law today

A federal judge on Thursday barred a tough new South Dakota abortion law from taking effect while it's being challenged in court. The law, which would have taken effect Friday, requires women seeking abortions to face a three-day waiting period and undergo counseling at pregnancy help centers that discourage abortion.

2 Jul 2011

NPR examines controversial drug being used to save women's lives

In another installment in NPR's summer-long series "Beginnings," NPR's All Things Considered aired a story on Wednesday examining how the controversial drug misoprostol is being used worldwide to save women's lives.

1 Jul 2011

Avoidance of routine thyroid testing on pregnant women would have let 80% of cases go undetected

A recent study completed by researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) demonstrates that BMC conducts a high rate of thyroid function testing in pregnant women.

1 Jul 2011

Viewpoints: Abortion law debates; Medicare cost examinations; state reform building blocks

The Susan B. Anthony List's Pro-Life Leadership Pledge has garnered praise from a number of Republican presidential candidates, including Rick Santorum, Michele Bachmann, Newt Gingrich, Ron Paul and Tim Pawlenty, each of whom has signed the pledge. It has also faced some misinformed criticism, however, not only from the media but from other presidential candidates who refuse to sign on to the pledge's four basic principles.

30 Jun 2011

VIVUS submits avanafil NDA to FDA for treatment of erectile dysfunction

VIVUS, Inc. today announced that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of avanafil, its investigational drug for the treatment of erectile dysfunction.

30 Jun 2011

Social stigma surrounding abortion

An international team of researchers says abortion stigma is under-researched, under theorized and over emphasized in one category: women who've had abortions. As a result, they're launching a new direction into research that explores the social stigma surrounding abortion.

30 Jun 2011

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.

30 Jun 2011

Tibotec, Gilead Sciences enter license agreement for new combination product of PREZISTA and cobicistat

Tibotec Pharmaceuticals today announced that it has entered into a license agreement with Gilead Sciences, Inc., for the development and commercialization of a new once-daily single tablet fixed-dose antiretroviral combination product containing Tibotec's protease inhibitor PREZISTA® (darunavir) and Gilead's cobicistat, an investigational pharmacoenhancing or "boosting" agent.

28 Jun 2011

Accelerated hepatitis B vaccination schedule effective for high-risk pregnant women

UT Southwestern Medical Center maternal-fetal specialists have confirmed a potential new protocol to protect pregnant women who are at risk for hepatitis B, a health problem that affects 2 billion people worldwide.

28 Jun 2011